Discovery of a selective alpha-kinase 1 inhibitor for the rare genetic disease ROSAH syndrome. This evidence concerns the gene ALPK1 and retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome.